Chart Tablets, Presentation Format (1 1/2 Rule), 25 White 24 X 16 Sheets

Pacon® Chart Tablet, 24 x 32, 1 1/2 Ruled, 25 Sheets : Chart Paper : Office Products

Get creative with your lesson plan with the Pacon Ruled Chart Tablet. The assorted color tablet is 1.5-inch ruled, and perfect for anchor charts, handwriting lessons, or for letting your imagination take control! The possibilities are endless with colored pages in yellow, pink, salmon, blue and green. The tablet comes with 25 pages of sulphite bond paper for demonstrating handwriting styles and programs or for anchor charts when reinforcing lessons.

Pacon Colored Paper Chart Tablet

Chart Tablets, Unruled, 25 White 24 X 32 Sheets

Features Standard-Weight Paper For Every-Day Use. Three-Hole Punched For Use In Standard Easels.

Easel Pads, Unruled, 50 White 27 X 34 Sheets, 2/Carton

Perfect for classroom demonstrations of handwriting, this chart tablet has white sulfite bond paper. Pages are two-hole punched.

Pacon® Chart Tablets, Presentation Format (1 Rule), 25 White 24 x 32 Sheets

A randomized double-blind placebo-controlled clinical trial of nitazoxanide for treatment of mild or moderate COVID-19 - eClinicalMedicine

Tops Single Carry Pack Easel Pad

Perfect for classroom demonstrations of handwriting, this chart tablet has white sulfite bond paper. Pages are two-hole punched. Pocket-Sized

Chart Tablets, Presentation Format (1 Rule), 25 White 24 X 16 Sheets | Bundle of 2 Each

School Smart Chart Tablet, 24 x 16 Inches, 1 Inch Rule, 25 Sheets : Office Products

Perfect for taking notes during presentations Ideal for class lessons and group discussions A great teacher tool for modeling letter formation and

School Smart-85337 Chart Tablet, 24 x 16 Inches, 1-1/2 Inch Skip Line, 25 Sheets - White

Pacon® Chart Tablet, 24 x 16, 1 1/2 Ruled, 25 Sheets : Office Products

Pacon Chart Tablet, White

Safety of age-dosed, single low-dose primaquine in children with glucose-6-phosphate dehydrogenase deficiency who are infected with Plasmodium falciparum in Uganda and the Democratic Republic of the Congo: a randomised, double-blind, placebo-controlled